Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Hypervirulent Klebsiella pneumoniae with hepatic abscess

Spelman D

(2023), 307-310

Management of suspected Epidural abscess

Spelman D

(2023), 303-306

A neuropathy in Infectious Disease

Spelman D

(2023), 299-302

Gastroenteritis complicated by mycotic aneurysm

Spelman D

(2023), 295-8

Fever of unknown origin

Spelman D

(2023), 291-4

Clinical significance of Staphylococcus Bacteriuria

Spelman D

(2023), 287-90

The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma Australia

Sim, S., Kalff, A., Tuch, G., Mollee, P., Ho, P. J., Harrison, S., Gibbs, S., Prince, H. M., Spencer, A., Joshua, D., Lee, C., Ling, S., Murphy, N., Szabo, F., Szer, J., Weber, N., Ward, C., Talaulikar, D., Zannettino, A., & Quach, H

(2023), Internal medicine journal, 53(5), 819-824

DOI: 10.1111/imj.16049

Congenital fibrinogen disorders: Strengthening genotype-phenotype correlations through novel genetic diagnostic tools.

Radha Ramanan, James D McFadyen, Andrew C Perkins, Huyen A Tran

(2023), British journal of haematology, 203(3), 355 368 355-368

DOI: 10.1111/bjh.19039

New Era for Myelofibrosis Treatment with Novel Agents Beyond JAK inhibitor Monotherapy: Focus on Clinical Development of BCL-XL/BCL2 inhibition With Navitoclax

Pemmaraju, N., Garcia, J. S., Perkins, A., Harb, J. G., Souers, A. J., Werner, M. E., Brown, C. M., & Passamonti, F

(2023), Cancer, 129(22), 3535-45

DOI: 10.1002/cncr.34986

Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe haemophilia A in the phase 3 trial GENEr8-1

O'Mahony B, Dunn AL, Leavitt AD, Peyvandi F, Ozelo MC, Mahlangu J, Peerlinck K, Wang JD, Lowe GC, Tan CW, Giermasz A, Tran H, Khoo TL, Cockrell E, Pepperell D, Chambost H, López Fernández MF, Kazmi R, Majerus E, Skinner MW, Klamroth R, Quinn J, Yu H, Wong WY, Robinson TM, Pipe SW.

(2023), Journal of thrombosis and haemostasis, 21(12), 3450–3462

DOI: 10.1016/j.jtha.2023.08.032

Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry

Nguyen J, Wellard C, Chung E, Cheah CY, Dickinson M, Doo NW, Keane C, Talaulikar D, Berkahn L, Morgan S, Hamad N, Cochrane T, Johnston AM, Forsyth C, Opat S, Barraclough A, Mutsando H, Ratnasingam S, Giri P, Wood EM, McQuilten ZK, Hawkes EA; Lymphoma and Related Diseases Registry investigators

(2023), European journal of haematology, 110(4), 386-95

DOI: 10.1111/ejh.13915

Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteria

Mu A, Klare WP, Baines SL, Ignatius Pang CN, Guérillot R, Harbison-Price N, Keller N, Wilksch J, Nhu NTK, Phan MD, Keller B, Nijagal B, Tull D, Dayalan S, Chua HHC, Skoneczny D, Koval J, Hachani A, Shah AD, Neha N, Jadhav S, Partridge SR, Cork AJ, Peters K, Bertolla O, Brouwer S, Hancock SJ, Álvarez-Fraga L, De Oliveira DMP, Forde B, Dale A, Mujchariyakul W, Walsh CJ, Monk I, Fitzgerald A, Lum M, Correa-Ospina C, Roy Chowdhury P, Parton RG, De Voss J, Beckett J, Monty F, McKinnon J, Song X, Stephen JR, Everest M, Bellgard MI, Tinning M, Leeming M, Hocking D, Jebeli L, Wang N, Ben Zakour N, Yasar SA, Vecchiarelli S, Russell T, Zaw T, Chen T, Teng D, Kassir Z, Lithgow T, Jenney A, Cole JN, Nizet V, Sorrell TC, Peleg AY, Paterson DL, Beatson SA, Wu J, Molloy MP, Syme AE, Goode RJA, Hunter AA, Bowland G, West NP, Wilkins MR, Djordjevic SP, Davies MR, Seemann T, Howden BP, Pascovici D, Tyagi S, Schittenhelm RB, De Souza DP, McConville MJ, Iredell JR, Cordwell SJ, Strugnell RA, Stinear TP, Schembri MA, Walker MJ

(2023), Nature communications, 14(1), 1530

DOI: 10.1038/s41467-023-37200-w

Patient-reported Outcomes and Quality of Life in Anemic and Symptomatic Patients With Myelofibrosis: Results From the MOMENTUM Study

Mesa RA, Harrison C, Palmer JM, Gupta V, McLornan DP, McMullin MF, Kiladjian JJ, Foltz L, Platzbecker U, Fox ML, Mead AJ, Ross DM, Oh ST, Perkins AC, Leahy MF, Kawashima J, Ro S, Donahue R, Gorsh B, Deheshi S, Verstovsek S

(2023), Hemasphere, 7(11), e966

DOI: 10.1097/HS9.0000000000000966

Effect of Low-Dose Aspirin Versus Placebo on Incidence of Anemia in the Elderly : A Secondary Analysis of the Aspirin in Reducing Events in the Elderly Trial

McQuilten, Z. K., Thao, L. T. P., Pasricha, S. R., Artz, A. S., Bailey, M., Chan, A. T., Cohen, H. J., Lockery, J. E., Murray, A. M., Nelson, M. R., Schneider, H. G., Wolfe, R., Woods, R. L., Wood, E. M., & McNeil, J. J

(2023), Annals of internal medicine, 176(7), 921

DOI: 10.7326/M23-0675

Phase 3 trial of concizumab in hemophilia with inhibitors

Matsushita T, Shapiro A, Abraham A, Angchaisuksiri P, Castaman G, Cepo K, d'Oiron R, Frei-Jones M, Goh AS, Haaning J, Hald Jacobsen S, Mahlangu J, Mathias M, Nogami K, Skovgaard Rasmussen J, Stasyshyn O, Tran H, Vilchevska K, Villarreal Martinez L, Windyga J, You CW, Zozulya N, Zulfikar B, Jiménez-Yuste V; explorer7 Investigators.

(2023), New England journal of medicine, 389(9), 783-794

DOI: 10.1056/NEJMoa2216455

The prognostic impact of t(11;14) in multiple myeloma: A real-world analysis from the Australian Lymphoma Leukaemia Group (ALLG) and the Australian Myeloma and Related Diseases Registry (MRDR)

Lim, K. J., Wellard, C., Talaulikar, D., Tan, J. L., Loh, J., Puvanakumar, P., Kuzich, J. A., Ho, M., Murphy, M., Zeglinas, N., Low, M. S., Routledge, D., Lim, A. B., Gibbs, S. D., Quach, H., Morgan, S., Moore, E., & Ninkovic, S

(2023), EJHaem, 4(3), 639-46

DOI: 10.1002/jha2.742

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study

Gerds AT, Verstovsek S, Vannucchi AM, Al-Ali HK, Lavie D, Kuykendall AT, Grosicki S, Iurlo A, Goh YT, Lazaroiu MC, Egyed M, Fox ML, McLornan D, Perkins A, Yoon SS, Gupta V, Kiladjian JJ, Granacher N, Lee SE, Ocroteala L, Passamonti F, Harrison CN, Oh S, Klencke BJ, Yu J, Donahue R, Kawashima J, Mesa R

(2023), Lancet Haematology, 10(9), e735-e746

DOI: 10.1016/S2352-3026(23)00174-6

Haemophilia joint score (HJHS) usage, patterns and outcome data in patients with haemophilia A and haemophilia B in Australia: a descriptive study using the Australian Bleeding Disorders Registry (ABDR)

George C, Parikh S, Carter T, Morris A, Cramey C, Mcelroy K, Tran H

(2023), Haemophilia, 29(4), 1135-1141

DOI: 10.1111/hae.14812

Evaluation of treatment and outcome for patients with haemophilia A and haemophilia B on extended half-life (EHL) factor products: A 12-month data analysis

George C, Parikh S, Carter T, Mccosker J, Carlino S, Tran H

(2023), Haemophilia, 29(5), 1283-1290

DOI: 10.1111/hae.14842

TP53 status and impact on AML prognosis within the ELN 2022 risk classification

Fleming S, Tsai XC, Morris R, Hou HA, Wei AH

(2023), Blood, 142(23), 2029-2033

DOI: 10.1182/blood.2023020855

3 4 5 6 7